InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Metagenomi Therapeutics, Inc.

MGX Clue Score24
United States Fiscal year ends December CIK 0001785279 Results filed 10 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

15
Insider
Date
Role
Action
Shares
Price
Amount
Laurence Reid
9 Sep 2026
Director
Buy
117
$1.18
$138.06
Laurence Reid
9 Sep 2026
Director
Buy
19,883
$1.17
$23.26K
Pamela Wapnick
8 Sep 2026
Chief Financial Officer
Sell
1,911
$1.16
$2.21K
Jian Irish
8 Sep 2026
See Remarks
Sell
2,140
$1.16
$2.48K
Matthew Wein
8 Sep 2026
See Remarks
Sell
358
$1.16
$414.71
Matthew Wein
5 Jun 2026
See Remarks
Sell
558
$1.30
$724.84
Jian Irish
5 Jun 2026
See Remarks
Sell
3,737
$1.30
$4.85K
Pamela Wapnick
5 Jun 2026
Chief Financial Officer
Sell
2,884
$1.30
$3.75K
Jian Irish
5 Mar 2026
Chief Executive Officer
Sell
1,607
$1.60
$2.57K
Matthew Wein
5 Mar 2026
See Remarks
Sell
482
$1.60
$771.20
Pamela Wapnick
5 Mar 2026
Chief Financial Officer
Sell
1,581
$1.60
$2.53K
Jian Irish
5 Dec 2025
Chief Executive Officer
Sell
1,602
$1.77
$2.84K
Pamela Wapnick
5 Dec 2025
Chief Financial Officer
Sell
1,576
$1.77
$2.79K
Matthew Wein
5 Dec 2025
See Remarks
Sell
199
$1.77
$352.61
Brian C. Thomas
5 Dec 2025
Director
Sell
3,830
$1.77
$6.79K

What was left out

Form 4 filings counted 25
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 13
Transactions with no price 0
Shares from compensation/vesting 773,962
History held since 14 Feb 2024